WPD Pharmaceuticals Inc.
WPD Pharmaceuticals Inc.
CSE Index:
NoCurrency:
CAD WPD Pharmaceuticals is a biotechnology research and development company. The Company operates in the pharmaceuticals industry with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. The Issuer is developing drugs which were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.
WPD Pharmaceuticals Inc. (WBIO)
0.07
0.00 (0.00%)
WPD Pharmaceuticals Inc. (WBIO)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
9,000
Bid Price
0.055
Ask Price
0.19
Ask Size
5,000
Volume
0
Last Price
0.07
Tick
Net Change
Prev Close
0.07
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
0.19
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.125
Tick
Net Change
Prev Close
0.125
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
9,000
Bid Price
0.055
Ask Price
0.19
Ask Size
5,000
Volume
0
Last Price
0.07
Tick
Net Change
Prev Close
0.07
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
0.19
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.125
Tick
Net Change
Prev Close
0.125
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| CIBC World Markets Inc. | 9,000 | 0.055 | 0.19 | 5,000 | National Bank Financial Inc. |
| 0 | 0.00 | 0.34 | 20,000 | Canaccord Capital Corporation | |
| 0 | 0.00 | 0.35 | 2,000 | Anonymous | |
| 0 | 0.00 | 0.55 | 2,000 | Anonymous | |
| 0 | 0.00 | 0.75 | 2,000 | Anonymous | |
| 0 | 0.00 | 0.95 | 2,000 | Anonymous | |
| 0 | 0.00 | 2.70 | 3,000 | National Bank Financial Inc. | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 1 | 9,000 | 0.055 | 0.19 | 5,000 | 1 |
| 0 | 0 | 0.00 | 0.34 | 20,000 | 1 |
| 0 | 0 | 0.00 | 0.35 | 2,000 | 1 |
| 0 | 0 | 0.00 | 0.55 | 2,000 | 1 |
| 0 | 0 | 0.00 | 0.75 | 2,000 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Feb 20, 19:09 | 0.07 | 0.00 | 5,000 | National Bank Financial Inc. | National Bank Financial Inc. | CSE |
| Feb 20, 19:09 | 0.07 | 0.00 | 3,000 | Canaccord Capital Corporation | National Bank Financial Inc. | CSE |
| Jan 31, 15:17 | 0.19 | 0.12 | 3,500 | Virtu Canada Corp. | BMO Nesbitt Burns Inc. | CSE |
| Jan 31, 15:17 | 0.19 | 0.12 | 500 | Virtu Canada Corp. | TD Securities Inc. | CSE |
| Jan 7, 15:27 | 0.19 | 0.12 | 1,000 | National Bank Financial Inc. | BMO Nesbitt Burns Inc. | CSE |
Company Info
Address
750 West Pender Street, Suite 401
Vancouver, BC V6C 2T7
CanadaPhone
604-561-2687Fax
604-565-3332Email
michael.malana@wpdpharmaceuticals.comListing date
Friday, December 27, 2019Transfer Agent
Computershare Investor Services Inc.SEDAR Information
Filing Type
Any
Material Change Report
News Releases
Management's Discussion & Analysis
Financial Statements
Timeframe
1 week1 month3 month6 month1 yearAll Time
WPD Pharmaceuticals Inc.
Date:
Aug 2, 2024
WPD Pharmaceuticals Inc.
Date:
Jun 26, 2024
WPD Pharmaceuticals Inc.
Date:
Jun 17, 2024
WPD Pharmaceuticals Inc.
Date:
May 7, 2024
WPD Pharmaceuticals Inc.
Date:
May 7, 2024
WPD Pharmaceuticals Inc.
Date:
Apr 10, 2024
WPD Pharmaceuticals Inc.
Date:
Jan 26, 2024
WPD Pharmaceuticals Inc.
Date:
Jan 26, 2024
WPD Pharmaceuticals Inc.
Date:
Jan 26, 2024
WPD Pharmaceuticals Inc.
Date:
Jan 26, 2024
WPD Pharmaceuticals Inc.
Date:
Jun 29, 2022
WPD Pharmaceuticals Inc.
Date:
Aug 26, 2021
WPD Pharmaceuticals Inc.
Date:
Aug 25, 2021
WPD Pharmaceuticals Inc.
Date:
Aug 4, 2021
WPD Pharmaceuticals Inc.
Date:
Jun 29, 2021
WPD Pharmaceuticals Inc.
Date:
Jun 3, 2021
WPD Pharmaceuticals Inc.
Date:
Jun 3, 2021
WPD Pharmaceuticals Inc.
Date:
Jul 30, 2020
WPD Pharmaceuticals Inc.
Date:
Jul 30, 2020
WPD Pharmaceuticals Inc.
Date:
Jul 8, 2019
WPD Pharmaceuticals Inc.
Date:
May 30, 2019
WPD Pharmaceuticals Inc.
Date:
May 30, 2019
WPD Pharmaceuticals Inc.
Date:
Jun 13, 2018
WPD Pharmaceuticals Inc.
Date:
Jun 13, 2018
WPD Pharmaceuticals Inc.
Date:
May 30, 2018
WPD Pharmaceuticals Inc.
Date:
May 30, 2018
WPD Pharmaceuticals Inc.
Date:
May 22, 2018
WPD Pharmaceuticals Inc.
Date:
May 30, 2017
WPD Pharmaceuticals Inc.
Date:
May 30, 2017
WPD Pharmaceuticals Inc.
Date:
Dec 30, 2016
WPD Pharmaceuticals Inc.
Date:
Dec 30, 2016
WPD Pharmaceuticals Inc.
Date:
Jun 1, 2015
WPD Pharmaceuticals Inc.
Date:
Nov 28, 2014
WPD Pharmaceuticals Inc.
Date:
May 29, 2014
WPD Pharmaceuticals Inc.
Date:
Jun 7, 2013
WPD Pharmaceuticals Inc.
Date:
Jun 7, 2013
WPD Pharmaceuticals Inc.
Date:
May 30, 2013
WPD Pharmaceuticals Inc.
Date:
May 29, 2012
WPD Pharmaceuticals Inc.
Date:
May 30, 2011
WPD Pharmaceuticals Inc.
Date:
Apr 20, 2011
Company Info
Address
750 West Pender Street, Suite 401
Vancouver, BC V6C 2T7
CanadaPhone
604-561-2687Fax
604-565-3332Email
michael.malana@wpdpharmaceuticals.comListing date
Friday, December 27, 2019Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
4639485Reserved for Issuance:
100600News Releases
Bulletins
23/12/2024
2024-1238 - Consolidation - WPD Pharmaceuticals Inc. (WBIO)
le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five (25) pre-consolidated common shares.
As a result, the outstanding shares of the company have been reduced to approximately 4,639,485 common shares.
The name and symbol will not change.
